Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Internal Medicine (Tokyo, Japan)|December 17, 2023
Overlap of Chronic Pulmonary Aspergillosis on Allergic Bronchopulmonary AspergillosisTakashi Ishiguro, Taisuke Isono, Tomoya Maruyama, et al.
Internal Medicine (Tokyo, Japan)|January 5, 2025
Predictive Factors for Invasive Mechanical Ventilation in Community-Acquired PneumoniaYoko Onodera, Takashi Ishiguro, Ryuji Uozumi, et al.
Internal Medicine (Tokyo, Japan)|January 21, 2020
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Complicated with Organizing PneumoniaChiaki Hosoda, Takashi Ishiguro, Yasuhiro Morimoto, et al.
Respiratory Medicine Case Reports|August 12, 2021
Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositisTaisuke Isono, Hiromi Nakajima, Kenji Takano, et al.
Internal Medicine (Tokyo, Japan)|June 21, 2021
Rheumatoid Arthritis Accompanying Diffuse PanbronchiolitisTaisuke Isono, Shun Shibata, Yuma Matsui, et al.
Respiratory Medicine Case Reports|November 12, 2019
Two cases of primary human parechovirus pneumonia in adultsTakashi Nishida, Takashi Ishiguro, Kenji Takano, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2024
Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the PandemicTaisuke Isono, Ayaka Kojima, Takashi Nishida, et al.
Internal Medicine (Tokyo, Japan)|March 26, 2026
Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint InhibitorsTaisuke Isono, Akihiro Ishida, Yoko Onodera, et al.
Internal Medicine (Tokyo, Japan)|September 1, 2020
Two Cases of Primary Rhinovirus Pneumonia with Multiple Pulmonary NodulesYasuhiro Morimoto, Takashi Ishiguro, Keisuke Kasuga, et al.
Thoracic Cancer|November 17, 2020
Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitorsTaisuke Isono, Naho Kagiyama, Kenji Takano, et al.
Pageof 2